Category Archives: PSA

Ten Things Physicians and Patients Should Question.

The “Chose Wisely” Israel Barken M.D., discusses the Choose Wisely program. The program created by cooperation between the American Board of Internal Medicine and the American Urological Association.

Posted in PSA, Sexual Dysfunction, Testosterone, Treatments for Prostate Cancer | Leave a comment

Percentage Involved Core Length and Risk of Recurrence After Radical Prostatectomy

Article: Greatest Percentage Involved Core Length and Risk of Clinically Significant Prostate-Specific Antigen Failure After Radical Prostatectomy. Author:  Anthony V. D’Amico Source: Clinical Genitourinary Cancer.  March 5, 2015

Posted in Biopsy, Prognosis, Prostate Cancer, PSA, Survival prostate cancer, Treatments for Prostate Cancer | Leave a comment

Phase III Prostvac Clinical Study

Immune Therapy is an important tool for advanced prostate cancer disease, especially in older patients for whom chemotherapy is excluded because of other serious medical problems. Dr. Barken presents the Prostvac Clinical Study Phase III with a video clip featuring … Continue reading

Posted in Active Surveillance, Ask Dr. Barken, Castration Resistant Prostate Cancer, Clinical Trials, Immune Therapy, Metastatic Disease, Prostate Cancer, PSA | Leave a comment

New Prostate Cancer Immunotherapy- Prostvac

Dr. Barken introduces the New Prostate Cancer Immune Therapy for earlier stages of Prostate Cancer.  Please watch the video below and see what  he learned at the National Cancer Institute recent conference mentioned above. Dr. James Gulley explains the Prostvac … Continue reading

Posted in Clinical Trials, Immune Therapy, Prostate Cancer, PSA, Treatments for Prostate Cancer | Tagged | Leave a comment

Enzalutamide and Prostvac for patients with PSA only disease after primary treatment

This very significant development could become the standard treatment for prostate cancer in the future.   Enzalutamide in Combination With PSA-TRICOM in Patients With Non-Metastatic Castration Sensitive Prostate Cancer. NIH Study- Recruiting-  Identifier: NCT01875250

Posted in Immune Therapy, Prostate Cancer, PSA, Radiation Therapy, Radical Prostatectomy | Leave a comment

Delaying Androgen Deprivation

Delaying Androgen Deprivation Therapy May not compromise Survival in Men with Prostate cancer and PSA-Only Relapse.

Posted in Hormonal Blockade, PSA, Radiation treatment, Radical Prostatectomy, Treatments for Prostate Cancer | Tagged | Leave a comment

Active Surveillance- Canadian Experience Part 2.

  Active Surveillance:  Current status and future direction. Part 2. Mayo Clinic Review, Hawaii Feb 2 2014 Produced by UroToday.      Click here to send me a question by sending a video.  Click to view instructions.

Posted in Active Surveillance, Biopsy, Imaging, PSA, Treatments for Prostate Cancer | Leave a comment